Company Filing History:
2 out of 4 
2 out of 8 
1 out of 1 Years Active: 2012-2016
Title: The Innovative Mind of Thomas Kruse
Introduction
Thomas Kruse is a distinguished inventor based in Copenhagen, Denmark. With a remarkable portfolio of five patents, he has made significant contributions to the field of biomedical innovations, particularly in the treatment of inflammatory conditions.
Latest Patents
Among his latest inventions is a patent focused on the treatment of inflammatory bowel diseases utilizing mammal beta defensins. This innovative approach harnesses the power of these peptides to address serious health conditions. Another notable patent involves the development of antimicrobial peptide variants and the corresponding polynucleotides encoding them. This invention encompasses nucleic acid constructs, vectors, and host cells that utilize these variants, highlighting his expertise in molecular biology and biotechnology.
Career Highlights
Throughout his career, Thomas has worked with several notable companies including Defensin Therapeutics ApS and Novozymes Adenium Biotech A/S. His experiences in these organizations have paved the way for his innovative contributions and further exploration in the field of medical biotechnology.
Collaborations
Thomas has collaborated with esteemed colleagues such as Per Holse Mygind and Tanja Maria Rosenkilde Kjaer. These partnerships reflect his commitment to advancing research and development in the biopharmaceutical sector.
Conclusion
Thomas Kruse's work exemplifies the spirit of innovation in the treatment of complex diseases. His patents not only represent significant scientific advancements but also showcase his dedication to improving health outcomes through innovative solutions. As he continues to explore new frontiers in his field, Kruse remains a prominent figure in the landscape of modern biomedical research.